U.S. patent number 3,592,245 [Application Number 04/762,063] was granted by the patent office on 1971-07-13 for universal dispensing device for intravenous medications.
This patent grant is currently assigned to American Home Products Corporation. Invention is credited to Stephen W. Goodsir, Ralph S. Levi, Howard J. Levin, George H. Schneller.
United States Patent |
3,592,245 |
Schneller , et al. |
July 13, 1971 |
UNIVERSAL DISPENSING DEVICE FOR INTRAVENOUS MEDICATIONS
Abstract
The disclosure is directed to a universal dispensing package for
medicaments to be dissolved in a parenteral container prior to use.
A container is provided with a cap which first, has a hollow
piercing device for dispensing a contained medicament into a
"closed system" parenteral solution container, and, second, has a
frustoconical shank adapted to engage the interior surface of the
neck of an "open system" parenteral solution container. A membrane
filter may be disposed between the container and the cap. An outer
sheath is provided over the cap and is scaled in place.
Inventors: |
Schneller; George H. (Devon,
PA), Levi; Ralph S. (Norristown, PA), Levin; Howard
J. (Norristown, PA), Goodsir; Stephen W. (King of
Prussia, PA) |
Assignee: |
American Home Products
Corporation (New York, NY)
|
Family
ID: |
25064002 |
Appl.
No.: |
04/762,063 |
Filed: |
September 24, 1968 |
Current U.S.
Class: |
141/25; 141/114;
215/228; 604/92; 141/24; 141/329; 215/308; 604/414 |
Current CPC
Class: |
B65D
47/06 (20130101); A61J 1/1468 (20150501); A61J
1/145 (20150501); A61J 1/1456 (20150501) |
Current International
Class: |
A61J
1/14 (20060101); B65D 47/06 (20060101); A61j
001/00 () |
Field of
Search: |
;128/272
;141/18,19,21--26,114,313,329,330 ;222/563 ;215/47 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
Primary Examiner: Geiger; Laverne D.
Assistant Examiner: Earls; Edward J.
Claims
What I claim is:
1. A dispensing package for medicaments to be added to a parenteral
solution prior to parenteral administration comprising:
A. a reservoir adapted to contain a medicament;
B. a conduit connected to said reservoir and adapted to convey said
medicament from said reservoir to a parenteral solution container
and having
1. A piercing device forming one end of said conduit and adapted to
pierce the closure of a closed-system parenteral solution
container, and
2. A tapered shank means having a taper of predetermined size to
sealably engage the inside of the neck of an open-system parenteral
solution container of predetermined size;
C. means to retain the medicament in said reservoir; and
D. means to retain said reservoir, said retaining means and said
conduit in abutting relation.
2. A package as defined in claim 1 wherein said reservoir is a
variable volume reservoir.
3. A package as defined in claim 2 in which said piercing device is
plastic.
4. A package as defined in claim 2 in which said piercing device is
metal.
5. A package as defined in claim 2 in which said tapered shank has
a patterned configuration defined in its outer surface.
6. A package as defined in claim 5 in which said patterned
configuration is fluting.
7. A package as defined in claim 2 in which said retaining means is
a membrane filter.
Description
This invention is directed to a universal dispensing package for
dispensing sterile medicaments and to a method for preparing
injectable solutions of such medicaments by transferring the
medicament from the dispensing package to a parenteral solution
container under substantially aseptic conditions. The dispensing
package is adapted to aseptically transfer its contents to both
"open system" and "closed system" parenteral solution containers.
An "open system" parenteral solution container, typically glass, is
one having a threaded closure which is removed in order to
discharge the contents. A "closed system" parenteral solution
container, typically glass, is one having a fixed plug, typically
rubber, which is perforated by a sharp conduit, typically a hollow
plastic needle, in order to remove the contents. Another type of
closed system which has recently become available is made of
flexible plastic and has a plastic membrane closure which is
perforated by a sharp conduit.
The method may be practiced by transferring a sterile medicament,
such as a powder, a lyophilized cake or a solution, to a parenteral
solution container of diluent adapted for parenteral injection,
irrigation or the like, the transfer being accomplished with
maximum protection to sterility.
It is common practice to add medicaments to parenteral solutions in
their containers at the time the parenteral solutions are
administered. The additives may be antibiotics such as sodium
ampicillin, muscle relaxants, such as succinylcholine chloride, and
others. The parenteral solution may be a saline solution,
glucose-saline solution or other isotonic solution, such as is
commonly employed for parenteral administration. Such solutions are
usually administered intravenously but may be otherwise
parenterally administered or may be used for irrigation.
The added medicaments are usually solutions, powders, or
lyophilized cakes. Previously available means for bringing the
powders or cakes into solution and for transferring the resulting
solution to the bulk parenteral solution have been cumbersome and
complicated and not devoid of risk to the sterility of the product
contained.
There are two principal forms of containers for the parenteral
solutions. More than half of the total market for intravenous
fluids is supplied in closed-system containers as they are defined
above, while the remainder of the market is supplied in open-type
containers as defined above. There are various dispensing packages
for medicaments to be used in conjunction with parenteral solution
containers. Typical packages are described in U.S. Pat. Nos.
2,957,501; 2,957,609; 3,059,643, and 3,143,251. There is, however,
no dispensing package available which may be used conveniently with
both the closed-system and open-system parenteral solution
containers with complete assurance of maintenance of sterility.
Numerous parenteral powders for reconstitution containing
antibiotics and other medicaments are commercially available. A
problem has been that in the manufacture of such powders, it is
extremely difficult to control the particulate matter content at a
satisfactory level and consequently the solutions ultimately
prepared from such powders often contain substantial particulate
matter counts. Commonly available antibiotics and other powdered
injectable products suffer from this disadvantage. Increasingly
higher standards for parenterals indicate that the amount of
particulate matter should be greatly reduced.
Even in the instances of drugs marketed in the form of solutions
which may be originally packaged substantially free of particulate
matter, it is well known to those skilled in the art that the
amount of particulate matter may increase substantially during the
shelf life of the product as a result of contact with package
components, trace drug decomposition and the like. Such solutions
after the development of the particulate matter are still suitable
for their intended use if the particulate matter is removed. The
particulate matter may not be visible to the naked eye, and
consequently the user may be unaware of its presence, and yet it
might be potentially harmful. A dispensing package which overcomes
this problem is described in copending application Ser. No.
742,872, filed by Howard J. Levin on July 5, 1968 and entitled
"Package". In that application a package utilizing a membrane
filter for the removal of particulate matter is disclosed.
It is an object of the present invention to provide apparatus for
the addition of medicaments to both open and closed-system
containers of intravenous parenteral mixtures which provides for
the filtration of the medication added to the intravenous
parenteral mixtures.
It is another object of the present invention to provide a
universal dispensing package for medicaments which are to be added
to parenteral solutions which may be used with powders that are not
free flowing or are hygroscopic, and can be used with liquids and
nonhygroscopic powders as well.
It is another object of the present invention to provide a method
of dissolving medicaments in a parenteral solution in a convenient
aseptic manner and which provides control of the particulate matter
contributed by the added medication.
Other and further objects of the present invention will be apparent
to those skilled in the art from reading the following description
taken in conjunction with the drawings, in which:
FIG. 1 is a sectional view of a dispensing package embodying the
features of the present invention;
FIG. 2 is a partial sectional view showing the embodiment of FIG. 1
in use in conjunction with a closed-system intravenous
container;
FIG. 3 is a partial sectional view showing the embodiment of FIG. 1
used in conjunction with an open-system intravenous container;
and
FIG. 4 is a detail view of an alternate embodiment of the
dispensing package of FIG. 1.
The objects of the present invention may be achieved with a
medicament dispensing package which is made up of a reservoir
adapted to contain the medicament, a substantially frustoconical
cap containing a conduit adapted to convey the medicament from the
reservoir to a parenteral solution container, and means to retain
the medicament in the reservoir during storage. The frustoconical
cap is shaped to have, first, a tapered shank portion adapted to
engage the interior surfaces of the mouth of an open-system
parenteral solution container and, second, a piercing device
adapted to pierce the closure of a closed-system parenteral
solution container. While the preferred embodiment utilizes a
variable-volume, plastic reservoir, a fixed-volume reservoir such
as a glass or plastic bottle may also be utilized.
A preferred embodiment of the present invention is shown in FIG. 1.
A universal dispensing package 10 is made up of a container, or
reservoir, 12, a cap 14, a filter 16, a protective sheath 18 and a
seal band 20, and contains a medicament 22. The container 12 has a
neck 24 provided with threads 26. At the lower portion of the neck
24 is an external flange 28 having a series of knurls, or lugs,
30.
The cap 14 has a shank 32 which has internal threads 34 adapted to
cooperate with the threads 26 of the neck 24 to provide a
screw-type engagement. The outer surface 36 of the shank 32 tapers
from a proximal periphery 31 to a distal periphery 33 and generally
defines a truncated cone, as shown. The outer surface 36 may have a
patterned configuration such as fluting 37, defined on it to adapt
it better to cooperate with the interior of the neck of an
open-system parenteral solution container as described below. A
transition piece 38 extends from the shank 32 and with it defines a
shoulder 40. A piercing device 42 is provided at the end of the
transition piece 38. The piercing device 42, the transition piece
38 and the shank 32 are hollow, and together define a conduit 44.
An inner surface 46 is defined in the shank and with the upper edge
portion 25 of the container 12 defines a seat for the filter
16.
The protective sheath 18 surrounds the entire cap 14 and is held in
place by the sealing band 20 which may surround the lower portion
of the protective sheath 18 and extend from a shoulder 48 on the
sheath to a point below the flange 28 and be crimped around the
flange. The knurls 30 prevent rotation of the sealing band 20.
The patterned configuration on the surface 36 may take one or more
of a number of forms designed to make the surface sufficiently
flexible sealably to engage the inner surface 60 of an open-system
parenteral solution container. To provide an effective seal the
form selected should be relatively short in extension from proximal
periphery 31 to distal periphery 33. The patterned configuration
may be formed by lightly roughening the surface 36. The surface
configuration may be formed by making a series of short
discontinuous cuts on the surface, for instance in the form of X's
or Y's. Other configurations are also effective. The preferred
form, however, is the fluting 37 which, as is shown in the
drawings, is a plurality of annular yieldable protuberances, or
depressions, defined in the outer surface 36.
While the preferred embodiment utilizes the filter 16 to retain the
medicament 22 and for other purposes, it is to be understood that
the filter may be eliminated and other means used to retain the
medicaments. In FIG. 4 is shown an alternative embodiment in which
a sheath 19 has a stud 50 formed in it. The stud 50 is adapted to
engage the channel 44 inside the piercing device 42. The stud thus
fills the end of the conduit, provides a tight seal, and retains
the medicament. The filter 16 may be omitted, if desired, in such
an embodiment.
The entire dispensing package 10 may be placed in an outerwrap of
plastic, metal foil, or combinations thereof or a rigid,
hermetically sealed container to control the ingress of water vapor
or other gases and to further assure the maintenance of
sterility.
In use the sealing band 20 and the protective sheath 18 are
removed. When used with a closed system intravenous container as
shown in FIG. 2, the piercing device 42 is inserted through a
sealing member 52 and a rubber stopper 53 of the closed-system
intravenous container 54. The conduit 44 provides communication
between the interior of the container 54 and the contents of the
dispensing package 10. Where the medicament 22 is a liquid, it is
readily discharged into the container 54 by compressing the sides
of the flexible container 12. The medicament 22 passes through the
filter 16 where any particles are removed. The steps may be
repeated to flush the container, if desired.
Where the medicament 22 is dry, the walls of the container 12 may
be compressed and the tip 42 submerged in the liquid 56 by
inverting the assembled system. A suitable portion of the liquid 56
may be drawn into the container 12 in order to dissolve the dry
medicament. To make this possible it may be necessary to relieve
any vacuum present. The reconstituted medicament solution may be
discharged from the package 10 by compressing the sides of the
container 12. The medicament 22 passes through the filter 16 where
any particles are removed.
In FIG. 3 is shown the dispensing package 10 in position to
discharge its contents into an open-system parenteral solution
container 58. The outer surface 36 of the shank 32 engages the
inner surface 60 of the container 58 and with it forms a tight
seal. The tightness of the seal may be increased by the formation
of a patterned configuration on the outer surface 36 of the shank
32 in order to develop a suitable friction seal. The medicament 22,
when liquid, may be discharged directly into the container 58.
Where the medicament is a solid, the package 10 and the parenteral
solution container 58 may be inverted and a portion of the fluid 59
drawn into the dispensing package 10 where, with gentle agitation
as necessary, it dissolves the medicament 22. The reconstituted
medicament solution may be discharged by again returning the
containers to the position shown in FIG. 3 and compressing the
flexible sides of the container 12.
The container 12 is preferably made of polyethylene, or similar
elastically recoverable material but may also be made of rigid
material such as glass if desired. The cap 14 is preferably made of
rigid polyethylene but may be made of any other suitable plastic or
metal. The piercing device 42 is typically made of the same
material as the remainder of the cap 14, but if desired may be of a
different material such as a metal or alloy. The protective sheath
18 or 19 and stud 50 are typically plastic but may be made of
rubber or other suitable materials. The seal band 20 may be made of
metal or plastic, and preferably is a plastic that shrinks on
drying.
The filter may be any suitable material, including sintered glass.
However, membrane filters are preferred. Membrane filters are a
class of thin filters composed of a porous matrix wherein the size
of the pores prevents any insoluble matter larger than the pores
from passing through the filter. When used for sterilization,
membranes are composed of pores small enough to prevent the passage
of microorganisms and thus render the solution sterile. The
membrane filter is usually composed of cellulose esters such as
cellulose acetate, cellulose triacetate, cellulose nitrate,
combination of cellulose acetate and nitrate, regenerated
cellulose, polyethylene, nylon, Teflon, polyvinyl chloride,
fluorinated vinyl, polypropylene, epoxy glass, acrylic vinyl
copolymer, or the like. The membrane filters useful in the practice
of the present invention customarily range in thickness from 25 to
300 microns and have a pore size range from about 0.005 micron to
10 microns, preferably from about 0.2 micron to 10 microns. The
filter may assume a variety of designs and embodiments to
accomplish its function. A preferred embodiment of the filter is
one that resembles a plate-and-frame filter and comprises at least
one membrane supported at its periphery. Filters having a pore size
range of 0.005 to 10 microns are commercially available. Filters
having pore sizes smaller than about 0.2 microns sterilize by
removing micro-organisms. Filters having a pore size range of about
3 to 10 microns are particularly useful in the preferred
embodiment.
The terms and expressions which have been employed are used as
terms of description and not of limitation, and there is no
intention in the use of such terms and expressions of excluding any
equivalents of the features shown and described or portions
thereof, but it is recognized that various modifications are
possible within the scope of the invention claimed.
* * * * *